Cardiovascular Devices are used in treating diseases related to the heart and the circulatory system. Cardiac Assist Devices are used to support the failing heart that cannot be managed with standard medical therapy. Mechanical Circulatory Support Devices replace or assist the pumping function of the ventricles. GlobalData uses proprietary data and analytics to provide a comprehensive report on the mechanical circulatory support devices devices market, including market shares of different players within Spain. Buy the latest report here.

Smarter leaders trust GlobalData

Report-cover

Data Insights United Kingdom Radiosurgery Systems Market Share

Buy the Report

Data Insights

The gold standard of business intelligence.

Find out more

In 2023, GlobalData’s Market Model methodology determined that the leading player in the mechanical circulatory support devices market in Spain was Abbott Laboratories followed by Syncardia Systems, Berlin Heart and Jarvik Heart.

Mechanical Circulatory Support Devices support the functioning of a weak heart by pumping blood. They can be used as a bridge to transplantation, for destination therapy, or as a bridge to recovery postcardiotomy. External/Paracorporeal Ventricular Assist Devices, Left Ventricular Assist Devices and Total Artificial Heart are tracked. Extracorporeal Membrane Oxygenators and Percutaneous Devices are not covered here. An External/Paracorporeal Ventricular Assist Device is a device that has a pump placed outside the body. An Implantable Left Ventricular Assist Device is a ventricular assist system intended for the treatment of end-stage heart failure. A Total Artificial Heart is a Prosthetic Device implanted into the body to replace the biological heart.

The value of the mechanical circulatory support devices devices market within Spain was expected to be over $10m in 2023.

For the latest complete market share analysis of mechanical circulatory support devices device market in Spain, buy the report here.

Data Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article. 

The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. Pipeline Products database is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.